Stay Ahead of Compliance with Monthly Citation Updates


In your State Survey window and need a snapshot of your risks?

Survey Preparedness Report

One Time Fee
$79
  • Last 12 months of citation data in one tailored report
  • Pinpoint the tags driving penalties in facilities like yours
  • Jump to regulations and pathways used by surveyors
  • Access to your report within 2 hours of purchase
  • Easily share it with your team - no registration needed
Get Your Report Now →

Monthly citation updates straight to your inbox for ongoing preparation?

Monthly Citation Reports

$18.90 per month
  • Latest citation updates delivered monthly to your email
  • Citations organized by compliance areas
  • Shared automatically with your team, by area
  • Customizable for your state(s) of interest
  • Direct links to CMS documentation relevant parts
Learn more →

Save Hours of Work with AI-Powered Plan of Correction Writer


One-Time Fee

$49 per Plan of Correction
Volume discounts available – save up to 20%
  • Quickly search for approved POC from other facilities
  • Instant access
  • Intuitive interface
  • No recurring fees
  • Save hours of work
F0684
E

Failure to Hold Medication and Monitor Labs per Physician Orders

Chambersburg, Pennsylvania Survey Completed on 07-31-2025

Penalty

No penalty information released
tooltip icon
The penalty, as released by CMS, applies to the entire inspection this citation is part of, covering all citations and f-tags issued, not just this specific f-tag. For the complete original report, please refer to the 'Details' section.

Summary

A deficiency occurred when a resident was readmitted to the facility with elevated liver transaminase levels and required assistance with personal care. The resident's hospital discharge summary and subsequent physician notes clearly instructed that atorvastatin therapy should be held until liver function tests returned to normal, and that liver enzyme laboratory work should be rechecked in a few weeks. Despite these instructions, the resident continued to receive atorvastatin daily from the time of readmission through several months, as documented in the Medication Administration Records for April, May, June, and July. There was no evidence in the clinical record that laboratory work to monitor liver enzymes was ordered or completed during this period. Interviews with the Director of Nursing confirmed that the expectation was for the medication to be held and for labs to be obtained in accordance with the physician's notes and plan of care. The failure to implement the resident-directed care and treatment as specified in the physician orders and plan of care resulted in the resident receiving medication contrary to medical instructions and without appropriate laboratory monitoring.

An unhandled error has occurred. Reload 🗙